Bruce Booth
Director at Kymera Therapeutics, Inc. (KYMR); Director at Sionna Therapeutics, Inc. (SION)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $248M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 5,5492,446,375 held (−0%) | $105.78 | $587K | +6.3% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 14,7982,431,577 held (−1%) | $106.63 | $1.6M | +5.4% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 19,4192,412,158 held (−1%) | $107.76 | $2.1M | +4.3% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 10,8482,401,310 held (−0%) | $108.28 | $1.2M | +3.8% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7,9682,393,342 held (−0%) | $109.75 | $874K | +2.4% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7,7232,385,619 held (−0%) | $110.67 | $855K | +1.6% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 9342,384,685 held (−0%) | $111.20 | $104K | +1.1% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 770471,497 held (−0%) | $105.78 | $81K | +6.3% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,133469,364 held (−0%) | $106.63 | $227K | +5.4% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,698466,666 held (−1%) | $107.76 | $291K | +4.3% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,498465,168 held (−0%) | $108.28 | $162K | +3.8% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,104464,064 held (−0%) | $109.75 | $121K | +2.4% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,078462,986 held (−0%) | $110.67 | $119K | +1.6% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 130462,856 held (−0%) | $111.20 | $14K | +1.1% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 10,6582,402,089 held (−0%) | $108.28 | $1.2M | +3.8% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7,8332,394,256 held (−0%) | $109.75 | $860K | +2.4% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7,6022,386,654 held (−0%) | $110.67 | $841K | +1.6% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 9072,385,747 held (−0%) | $111.20 | $101K | +1.1% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,688464,389 held (−0%) | $108.28 | $183K | +3.8% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,239463,150 held (−0%) | $109.75 | $136K | +2.4% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,199461,951 held (−0%) | $110.67 | $133K | +1.6% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 157461,794 held (−0%) | $111.20 | $17K | +1.1% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 28,2962,834,055 held (−1%) | $107.57 | $3.0M | +4.5% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 231,0072,603,048 held (−8%) | $108.14 | $25.0M | +3.9% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 32,6242,570,424 held (−1%) | $109.79 | $3.6M | +2.4% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 11,2772,559,147 held (−0%) | $110.49 | $1.2M | +1.7% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 10,3662,548,781 held (−0%) | $111.51 | $1.2M | +0.8% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 5552,548,226 held (−0%) | $112.49 | $62K | -0.1% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 14,9132,533,313 held (−1%) | $113.97 | $1.7M | -1.4% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 27,9512,505,362 held (−1%) | $114.94 | $3.2M | -2.2% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 6,8212,498,541 held (−0%) | $115.69 | $789K | -2.8% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 12,1812,486,360 held (−0%) | $117.09 | $1.4M | -4.0% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 22,0462,464,314 held (−1%) | $117.85 | $2.6M | -4.6% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 12,3902,451,924 held (−1%) | $118.66 | $1.5M | -5.3% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,958525,760 held (−1%) | $107.57 | $426K | +4.5% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 32,402493,358 held (−6%) | $108.14 | $3.5M | +3.9% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 4,562488,796 held (−1%) | $109.79 | $501K | +2.4% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,579487,217 held (−0%) | $110.49 | $174K | +1.7% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,442485,775 held (−0%) | $111.51 | $161K | +0.8% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 78485,697 held (−0%) | $112.49 | $9K | -0.1% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,083483,614 held (−0%) | $113.97 | $237K | -1.4% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,896479,718 held (−1%) | $114.94 | $448K | -2.2% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 952478,766 held (−0%) | $115.69 | $110K | -2.8% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,701477,065 held (−0%) | $117.09 | $199K | -4.0% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,069473,996 held (−1%) | $117.85 | $362K | -4.6% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,729472,267 held (−0%) | $118.66 | $205K | -5.3% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 5,4712,446,453 held (−0%) | $105.78 | $579K | +6.3% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 14,6132,431,840 held (−1%) | $106.63 | $1.6M | +5.4% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 19,0932,412,747 held (−1%) | $107.76 | $2.1M | +4.3% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 848471,419 held (−0%) | $105.78 | $90K | +6.3% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,318469,101 held (−0%) | $106.63 | $247K | +5.4% |
| Jun 30SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,024466,077 held (−1%) | $107.76 | $326K | +4.3% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,2353,461,521 held (−0%) | $99.98 | $123K | +12.4% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 173613,589 held (−0%) | $99.98 | $17K | +12.4% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 103,6883,357,833 held (−3%) | $100.42 | $10.4M | +11.9% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 14,513599,076 held (−2%) | $100.42 | $1.5M | +11.9% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 14,4903,343,343 held (−0%) | $101.14 | $1.5M | +11.1% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,029597,047 held (−0%) | $101.14 | $205K | +11.1% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 9,9943,333,349 held (−0%) | $107.30 | $1.1M | +4.8% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1593,333,190 held (−0%) | $108.02 | $17K | +4.1% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 14,3513,318,839 held (−0%) | $108.83 | $1.6M | +3.3% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,9153,316,924 held (−0%) | $110.30 | $211K | +1.9% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 6143,316,310 held (−0%) | $110.79 | $68K | +1.5% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7193,315,591 held (−0%) | $111.89 | $80K | +0.5% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 10,2153,305,376 held (−0%) | $113.70 | $1.2M | -1.1% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 9,2293,296,147 held (−0%) | $114.65 | $1.1M | -2.0% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 58,2053,237,942 held (−2%) | $115.57 | $6.7M | -2.7% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 81,5003,156,442 held (−3%) | $116.53 | $9.5M | -3.5% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 24,2683,132,174 held (−1%) | $117.50 | $2.9M | -4.3% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 19,0893,113,085 held (−1%) | $118.60 | $2.3M | -5.2% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,399595,648 held (−0%) | $107.30 | $150K | +4.8% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 23595,625 held (−0%) | $108.02 | $2K | +4.1% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,011593,614 held (−0%) | $108.83 | $219K | +3.3% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 265593,349 held (−0%) | $110.30 | $29K | +1.9% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 86593,263 held (−0%) | $110.79 | $10K | +1.5% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 100593,163 held (−0%) | $111.89 | $11K | +0.5% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,437591,726 held (−0%) | $113.70 | $163K | -1.1% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,289590,437 held (−0%) | $114.65 | $148K | -2.0% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 8,389582,048 held (−1%) | $115.57 | $970K | -2.7% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 11,375570,673 held (−2%) | $116.53 | $1.3M | -3.5% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,359567,314 held (−1%) | $117.50 | $395K | -4.3% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,646564,668 held (−0%) | $118.60 | $314K | -5.2% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 37,1793,075,906 held (−1%) | $119.71 | $4.5M | -6.1% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 112,2992,963,607 held (−4%) | $120.66 | $13.5M | -6.8% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 40,7742,922,833 held (−1%) | $121.38 | $4.9M | -7.4% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 4,9772,917,856 held (−0%) | $122.67 | $611K | -8.4% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 10,8602,906,996 held (−0%) | $123.62 | $1.3M | -9.1% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 11,7112,895,285 held (−0%) | $124.61 | $1.5M | -9.8% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,7162,891,569 held (−0%) | $125.82 | $468K | -10.7% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,6092,889,960 held (−0%) | $126.71 | $204K | -11.3% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 25,0752,864,885 held (−1%) | $127.37 | $3.2M | -11.8% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,1972,862,688 held (−0%) | $128.69 | $283K | -12.7% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3372,862,351 held (−0%) | $129.61 | $44K | -13.3% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 5,144559,524 held (−1%) | $119.71 | $616K | -6.1% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 15,660543,864 held (−3%) | $120.66 | $1.9M | -6.8% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 5,689538,175 held (−1%) | $121.38 | $691K | -7.4% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 698537,477 held (−0%) | $122.67 | $86K | -8.4% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,517535,960 held (−0%) | $123.62 | $188K | -9.1% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,639534,321 held (−0%) | $124.61 | $204K | -9.8% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 522533,799 held (−0%) | $125.82 | $66K | -10.7% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 223533,576 held (−0%) | $126.71 | $28K | -11.3% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,507530,069 held (−1%) | $127.37 | $447K | -11.8% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 305529,764 held (−0%) | $128.69 | $39K | -12.7% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 46529,718 held (−0%) | $129.61 | $6K | -13.3% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 18,3133,472,340 held (−1%) | $103.42 | $1.9M | +8.7% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 9,5843,462,756 held (−0%) | $104.38 | $1.0M | +7.7% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,560615,103 held (−0%) | $103.42 | $265K | +8.7% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,341613,762 held (−0%) | $104.38 | $140K | +7.7% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 11,741 | $89.98 | $1.1M | +24.9% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 92,1693,807,660 held (−2%) | $90.38 | $8.3M | +24.4% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 12,902662,042 held (−2%) | $90.38 | $1.2M | +24.4% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 62,8973,744,763 held (−2%) | $90.48 | $5.7M | +24.2% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 32,3593,712,404 held (−1%) | $91.85 | $3.0M | +22.4% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 5,6723,706,732 held (−0%) | $92.16 | $523K | +22.0% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 8,809653,233 held (−1%) | $90.48 | $797K | +24.2% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 4,526648,707 held (−1%) | $91.85 | $416K | +22.4% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 793647,914 held (−0%) | $92.16 | $73K | +22.0% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 14,9213,691,811 held (−0%) | $92.14 | $1.4M | +22.0% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,0353,689,776 held (−0%) | $94.48 | $192K | +19.0% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 11,7833,677,993 held (−0%) | $95.12 | $1.1M | +18.2% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 20,9033,657,090 held (−1%) | $96.24 | $2.0M | +16.8% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 16,0843,641,006 held (−0%) | $97.68 | $1.6M | +15.1% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 25,9763,615,030 held (−1%) | $98.58 | $2.6M | +14.0% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 52,4423,562,588 held (−1%) | $99.57 | $5.2M | +12.9% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 56,3483,506,240 held (−2%) | $100.17 | $5.6M | +12.2% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 6,5973,499,643 held (−0%) | $101.61 | $670K | +10.6% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 8,9903,490,653 held (−0%) | $102.48 | $921K | +9.7% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,179645,735 held (−0%) | $92.14 | $201K | +22.0% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 286645,449 held (−0%) | $94.48 | $27K | +19.0% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,648643,801 held (−0%) | $95.12 | $157K | +18.2% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,919640,882 held (−0%) | $96.24 | $281K | +16.8% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,247638,635 held (−0%) | $97.68 | $219K | +15.1% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,603635,032 held (−1%) | $98.58 | $355K | +14.0% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7,319627,713 held (−1%) | $99.57 | $729K | +12.9% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7,879619,834 held (−1%) | $100.17 | $789K | +12.2% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 918618,916 held (−0%) | $101.61 | $93K | +10.6% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,253617,663 held (−0%) | $102.48 | $128K | +9.7% |
| Apr 24SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 5,900 | $89.96 | $531K | +24.9% |
| Apr 24SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 883,899,829 held (−0%) | $90.08 | $8K | +24.8% |
| Apr 24SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 12674,944 held (−0%) | $90.08 | $1K | +24.8% |
| Apr 16SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 4,159 | $89.97 | $374K | +24.9% |
| Apr 16SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,200 | $89.95 | $198K | +25.0% |
| Apr 16SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,7503,899,917 held (−0%) | $90.10 | $248K | +24.8% |
| Apr 16SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 385674,956 held (−0%) | $90.10 | $35K | +24.8% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 71,8143,902,667 held (−2%) | $90.13 | $6.5M | +24.7% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 10,052675,341 held (−1%) | $90.13 | $906K | +24.7% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 31,4594,141,757 held (−1%) | $88.64 | $2.8M | +26.8% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 17,8254,123,932 held (−0%) | $89.25 | $1.6M | +25.9% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 10,5454,113,387 held (−0%) | $90.14 | $951K | +24.7% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 47,3494,066,038 held (−1%) | $92.41 | $4.4M | +21.6% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 85,8623,980,176 held (−2%) | $93.20 | $8.0M | +20.6% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 5,979717,267 held (−1%) | $88.64 | $530K | +26.8% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 3,391713,876 held (−0%) | $89.25 | $303K | +25.9% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 2,001711,875 held (−0%) | $90.14 | $180K | +24.7% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 9,060702,815 held (−1%) | $92.41 | $837K | +21.6% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 16,338686,477 held (−2%) | $93.20 | $1.5M | +20.6% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 5,1253,975,051 held (−0%) | $91.23 | $468K | +23.2% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 976685,501 held (−0%) | $91.23 | $89K | +23.2% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 5703,974,481 held (−0%) | $91.04 | $52K | +23.5% |
| Dec 12SEC | KYMRKymera Therapeutics, Inc. | Sell | 108685,393 held (−0%) | $91.04 | $10K | +23.5% |
| Oct 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 22,3392,360,156 held (−1%) | $32.69 | $730K | -85.0% |
| Oct 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 4,688697,297 held (−1%) | $32.69 | $153K | -85.0% |
| Oct 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 19,9482,340,208 held (−1%) | $33.87 | $676K | -85.5% |
| Oct 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 4,187693,110 held (−1%) | $33.87 | $142K | -85.5% |
| Oct 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 5,7632,334,445 held (−0%) | $34.91 | $201K | -86.0% |
| Oct 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 1,210691,900 held (−0%) | $34.91 | $42K | -86.0% |
| Oct 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 25,3272,309,118 held (−1%) | $35.69 | $904K | -86.3% |
| Oct 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 5,316686,584 held (−1%) | $35.69 | $190K | -86.3% |
| Oct 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 832,309,035 held (−0%) | $36.42 | $3K | -86.5% |
| Oct 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 17686,567 held (−0%) | $36.42 | $619 | -86.5% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 8,5962,610,589 held (−0%) | $30.15 | $259K | -83.7% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 1,804749,860 held (−0%) | $30.15 | $54K | -83.7% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 45,1172,565,472 held (−2%) | $31.69 | $1.4M | -84.5% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 9,470740,390 held (−1%) | $31.69 | $300K | -84.5% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 73,2962,492,176 held (−3%) | $32.84 | $2.4M | -85.1% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 15,384725,006 held (−2%) | $32.84 | $505K | -85.1% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 12,8882,479,288 held (−1%) | $33.38 | $430K | -85.3% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 2,705722,301 held (−0%) | $33.38 | $90K | -85.3% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 28,8212,450,467 held (−1%) | $32.10 | $925K | -84.7% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 6,049716,252 held (−1%) | $32.10 | $194K | -84.7% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 21,4512,429,016 held (−1%) | $32.71 | $702K | -85.0% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 4,503711,749 held (−1%) | $32.71 | $147K | -85.0% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 2482,428,768 held (−0%) | $33.47 | $8K | -85.4% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 52711,697 held (−0%) | $33.47 | $2K | -85.4% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 20,4852,408,283 held (−1%) | $31.79 | $651K | -84.6% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 4,300707,397 held (−1%) | $31.79 | $137K | -84.6% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 25,7882,382,495 held (−1%) | $32.33 | $834K | -84.8% |
| Oct 20SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 5,412701,985 held (−1%) | $32.33 | $175K | -84.8% |
| Oct 15SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 16,7272,763,574 held (−1%) | $29.98 | $501K | -83.7% |
| Oct 15SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 3,511781,969 held (−0%) | $29.98 | $105K | -83.7% |
| Oct 15SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 44,0482,719,526 held (−2%) | $30.32 | $1.3M | -83.8% |
| Oct 15SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 9,245772,724 held (−1%) | $30.32 | $280K | -83.8% |
| Oct 15SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 4,0822,715,444 held (−0%) | $31.03 | $127K | -84.2% |
| Oct 15SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 857771,867 held (−0%) | $31.03 | $27K | -84.2% |
| Oct 15SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 5012,714,943 held (−0%) | $29.95 | $15K | -83.6% |
| Oct 15SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 105771,762 held (−0%) | $29.95 | $3K | -83.6% |
| Oct 15SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 65,7262,649,217 held (−2%) | $30.37 | $2.0M | -83.9% |
| Oct 15SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 13,795757,967 held (−2%) | $30.37 | $419K | -83.9% |
| Oct 15SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 30,0322,619,185 held (−1%) | $31.12 | $935K | -84.3% |
| Oct 15SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 6,303751,664 held (−1%) | $31.12 | $196K | -84.3% |
- Sell
Director Bruce Booth sold $587K of KYMR at $105.78 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Bruce Booth sold $1.6M of KYMR at $106.63 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Bruce Booth sold $2.1M of KYMR at $107.76 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Bruce Booth sold $1.2M of KYMR at $108.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Bruce Booth sold $874K of KYMR at $109.75 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Bruce Booth sold $855K of KYMR at $110.67 — pre-scheduled 10b5-1 plan sale.